Cas no 894365-26-5 (5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde)

5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde is a versatile benzaldehyde derivative featuring a 1,2,4-triazole substituent. This compound is of interest in organic synthesis and pharmaceutical research due to its reactive aldehyde group and the presence of a heterocyclic moiety, which enhances its potential as a building block for more complex molecules. The methyl groups at the 2- and 4-positions contribute to steric and electronic modulation, influencing reactivity and selectivity in subsequent transformations. Its structural features make it suitable for applications in medicinal chemistry, particularly in the development of triazole-containing bioactive compounds. The product is typically characterized by high purity and stability under standard storage conditions.
5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde structure
894365-26-5 structure
Product Name:5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde
CAS No:894365-26-5
MF:C12H13N3O
MW:215.251122236252
MDL:MFCD07162613
CID:1086872
PubChem ID:17326283
Update Time:2025-10-29

5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde Chemical and Physical Properties

Names and Identifiers

    • 5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde
    • 2,4-dimethyl-5-(1,2,4-triazol-1-ylmethyl)benzaldehyde
    • 2,4-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde(SALTDATA: FREE)
    • CHEMBRDG-BB 9071543
    • 2,4-DIMETHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)BENZALDEHYDE
    • MFCD07162613
    • 894365-26-5
    • 2,4-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde, AldrichCPR
    • DTXSID30589510
    • 2,4-Dimethyl-5-[(1H-1,2,4-triazol-1-yl)methyl]benzaldehyde
    • AKOS022185193
    • MDL: MFCD07162613
    • Inchi: 1S/C12H13N3O/c1-9-3-10(2)12(6-16)4-11(9)5-15-8-13-7-14-15/h3-4,6-8H,5H2,1-2H3
    • InChI Key: BXYIAQSNCWYCCG-UHFFFAOYSA-N
    • SMILES: O=CC1C(C)=CC(C)=C(C=1)CN1C=NC=N1

Computed Properties

  • Exact Mass: 215.10600
  • Monoisotopic Mass: 215.105862047g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 16
  • Rotatable Bond Count: 3
  • Complexity: 246
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 1.8
  • Topological Polar Surface Area: 47.8?2

Experimental Properties

  • PSA: 47.78000
  • LogP: 1.75570

5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde Customs Data

  • HS CODE:2933990090
  • Customs Data:

    China Customs Code:

    2933990090

    Overview:

    2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date

    Summary:

    2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
abcr
AB222080-250 mg
2,4-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde; 95%
894365-26-5
250MG
€132.40 2022-06-11
abcr
AB222080-1 g
2,4-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde, 95%; .
894365-26-5 95%
1 g
€367.20 2023-07-20
abcr
AB222080-1g
2,4-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)benzaldehyde, 95%; .
894365-26-5 95%
1g
€367.20 2025-04-15

Additional information on 5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde

5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde: A Versatile Chemical Entity in Modern Pharmaceutical and Material Science

5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde is a multifunctional organic compound that has garnered significant attention in the fields of medicinal chemistry, material science, and biochemical research. This molecule, with the chemical formula C14H14N2O, is characterized by its unique structural features, including the presence of a 1,2,4-triazole ring and a benzaldehyde group. The dimethyl substituents on the benzene ring further enhance its chemical reactivity and functional versatility. The compound's synthesis and applications are closely tied to its molecular architecture, which allows for interactions with biological targets and materials engineering applications.

Recent studies have highlighted the potential of 5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde in modulating cellular processes and its role as a scaffold for drug development. The 1,2,4-triazole ring, a well-known heterocyclic structure, is frequently employed in pharmaceuticals due to its ability to form hydrogen bonds and exhibit diverse pharmacological activities. The benzaldehyde moiety, on the other hand, contributes to the molecule's aromaticity and potential for conjugation with other functional groups. Together, these features make the compound a promising candidate for further exploration in therapeutic and industrial contexts.

The 1,2,4-triazole core in 5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde is particularly noteworthy for its involvement in the design of antiviral and anti-inflammatory agents. Research published in 2023 demonstrated that derivatives of this structure exhibit significant inhibitory effects against RNA-dependent RNA polymerases (RdRp), a key enzyme in viral replication. This finding underscores the importance of the 1,2,4-triazole ring in enhancing the molecule's biological activity. Additionally, the dimethyl groups on the benzene ring may influence the molecule's solubility and membrane permeability, which are critical factors in drug delivery systems.

From a synthetic perspective, the preparation of 5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde typically involves the condensation of a benzaldehyde derivative with a 1,2,4-triazole precursor. This reaction, often catalyzed by acid or base, leads to the formation of a stable carbon-nitrogen bond, which is essential for the molecule's structural integrity. The presence of dimethyl substituents on the benzene ring may also affect the reaction kinetics and stereochemistry of the final product. Optimization of reaction conditions, such as temperature, solvent, and catalyst selection, is crucial for achieving high yields and purity in the synthesis of this compound.

Recent advances in computational chemistry have provided new insights into the molecular interactions of 5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde. Molecular docking studies have revealed that the 1,2,4-triazole ring can form hydrogen bonds with specific amino acid residues in target proteins, such as serine and threonine. This interaction is believed to be responsible for the molecule's ability to modulate enzyme activity and cellular signaling pathways. Furthermore, the benzaldehyde group may engage in π-π stacking interactions with aromatic residues in the protein's active site, further stabilizing the binding complex.

Applications of 5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde extend beyond pharmaceuticals into the realm of material science. The compound's aromatic structure and functional groups make it a valuable building block for the synthesis of polymers, nanomaterials, and molecular probes. For instance, researchers have explored the use of this molecule as a fluorescent tag for bioimaging applications. The 1,2,4-triazole ring can be conjugated with fluorescent dyes, enabling the visualization of cellular processes in real-time. Such applications highlight the molecule's potential in both biological and industrial contexts.

The dimethyl substituents on the benzene ring also play a critical role in the molecule's solubility and compatibility with different solvents. This property is particularly important in the development of drug formulations, where the solubility of the active compound directly affects its bioavailability. Studies have shown that the introduction of dimethyl groups can enhance the solubility of the molecule in polar solvents, making it more suitable for oral administration. This characteristic is a key consideration in the design of pharmaceutical agents that require systemic delivery.

In the context of green chemistry, the synthesis of 5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde has been optimized to minimize environmental impact. Recent work has focused on using catalytic methods and recyclable reagents to reduce waste generation and energy consumption. These efforts align with the growing emphasis on sustainable practices in chemical synthesis, ensuring that the development of such compounds is both economically viable and environmentally responsible.

Despite its promising applications, the 1,2,4-triazole ring in 5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde may also present challenges in terms of toxicity and metabolic stability. Preclinical studies are essential to evaluate the safety profile of the molecule and its derivatives. For example, some compounds containing the 1,2,4-triazole ring have been associated with hepatotoxicity, necessitating careful optimization of their chemical structure to mitigate such risks. These findings underscore the importance of thorough toxicological assessment in the development of new pharmaceutical agents.

Looking ahead, the future of 5-((1H-1,2,4-Triazol-1-yl)methyl)-2,4-dimethylbenzaldehyde lies in its potential to be a versatile platform for the design of novel therapeutics and materials. Advances in synthetic methodologies, computational modeling, and biocompatibility testing are expected to further expand its applications. As research continues to uncover new properties and interactions of this molecule, its significance in both scientific and industrial domains is likely to grow, solidifying its role as a key compound in modern chemistry.

Recommended suppliers
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hebei Liye chemical Co.,Ltd
Inner Mongolia Xinhong Biological Technology Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Inner Mongolia Xinhong Biological Technology Co., Ltd
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Suzhou Senfeida Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Senfeida Chemical Co., Ltd
Wuhan ChemNorm Biotech Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Wuhan ChemNorm Biotech Co.,Ltd.